Channel 1
Multidisciplinary tumour board
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Room
Channel 1
Neoadjuvant/adjuvant treatment of HER2+
Multidisciplinary tumour board
Live introduction (ID 295)
Lecture Time
15:45 - 15:50
Speakers
Session Name
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+
Multidisciplinary tumour board
Evaluation of HER2 status: What else needs to be known (ID 296)
Lecture Time
15:50 - 16:05
Speakers
Session Name
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+
Multidisciplinary tumour board
Can we cure oligometastatic HER2+ disease? (ID 297)
Lecture Time
16:05 - 16:20
Session Name
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+
Multidisciplinary tumour board
Should we maximise HER2 blockade for triple positive disease? (ID 298)
Lecture Time
16:20 - 16:35
Speakers
Session Name
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+
Multidisciplinary tumour board
Surgery in the time of pathological complete responses: How to adapt to better systemic therapy? (ID 299)
Lecture Time
16:35 - 16:50
Speakers
Session Name
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00
Neoadjuvant/adjuvant treatment of HER2+
Multidisciplinary tumour board
Q&A and live discussion (ID 300)
Lecture Time
16:50 - 17:00
Speakers
Session Name
Room
Channel 1
Date
Fri, 07.05.2021
Time
15:45 - 17:00